Generex Biotechnology Corporation (GNBT) and trades at $0.00. The 52-week range is 1.0E-4-0.1393.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-0.46, annual revenue of $2.66M.
The stock has a beta of -0.06, operates in the Healthcare sector.
